Matt Brown Show

Biotricity creates leading-edge professional and personal remote medical monitoring technology engineered to improve people's lives. Biotricity listed on the Nasdaq only 5 years into their journey. Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, has surpassed $10 million in annual revenue run rate. Biotricity boasts multiple ground-breaking products including Bioflux®, Biotres, and Bioheart which won TIME's Best Inventions of 2022. Bioflux: a high-precision, single-unit mobile cardiac telemetry (MCT) device that provides real-time monitoring and transmission of your ECG information to your doctor Biotres: an easy to wear, rechargeable device with wireless capability, utilizing the advanced technology of the Bioflux® for more active days Bioheart: a consumer-targeted continuous heart rhythm monitor that uses the most advanced heart technology to deliver unlimited heart data insights with three views of